In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson
Portfolio Pulse from Benzinga Insights
The article provides an in-depth examination of 11 analyst recommendations for Johnson & Johnson (NYSE:JNJ) over the past quarter. Analysts' opinions range from bullish to bearish, with the majority being somewhat bullish. The average 12-month price target is $184.27, reflecting a 2.82% increase from the previous average. Key analysts from firms like RBC Capital, Cantor Fitzgerald, HSBC, Morgan Stanley, and B of A Securities have maintained, raised, or lowered their ratings and price targets for JNJ. The article also highlights JNJ's financial performance, including revenue growth, net margin, ROE, ROA, and debt management.
June 17, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed views on Johnson & Johnson (NYSE:JNJ) with a majority being somewhat bullish. The average 12-month price target is $184.27, reflecting a 2.82% increase from the previous average. Key analysts from RBC Capital, Cantor Fitzgerald, HSBC, Morgan Stanley, and B of A Securities have maintained, raised, or lowered their ratings and price targets for JNJ.
The majority of analysts are somewhat bullish on JNJ, and the average price target has increased by 2.82%. This positive sentiment, combined with strong financial metrics, suggests a likely short-term upward movement in JNJ's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100